Cargando…

A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities

INTRODUCTION: Interleukin-15 (IL-15) is an immunomodulatory cytokine. It can activate and expand cytotoxic CD8 T lymphocytes and natural killer cells, leading to potent antitumor effects. Various forms of IL-15 are now in different stages of development for cancer immunotherapy. One of the major iss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yue, Wang, Yanlan, Xing, Jieyu, Li, Yumei, Liu, Jiayu, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120566/ https://www.ncbi.nlm.nih.gov/pubmed/30214153 http://dx.doi.org/10.2147/DDDT.S166373

Ejemplares similares

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
por: Pan, Haitao, et al.
Publicado: (2018)

A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
por: Wu, Xiaoqiong, et al.
Publicado: (2018)

CEA adhesion molecules: multifunctional proteins with signal-regulatory properties
por: Öbrink, Björn
Publicado: (1997)

Potent and Specific Antitumor Effect for Colorectal Cancer by CEA and Rb Double Regulated Oncolytic Adenovirus Harboring ST13 Gene
por: Zhou, Xiumei, et al.
Publicado: (2012)

Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor Activities
por: Liu, Jiayu, et al.
Publicado: (2019)

A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells
por: Li, Yumei, et al.
Publicado: (2022)

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
por: Miyazaki, Takahiro, et al.
Publicado: (2021)

Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
por: Wu, Song, et al.
Publicado: (2018)

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation
por: Kujawski, Maciej, et al.
Publicado: (2020)

Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
por: Kowalsky, Stacy J., et al.
Publicado: (2018)

Interleukin-15 (IL-15) and IL-15 receptor alpha fusion protein enhances antitumor activity of myxoma virus
por: Tosic, Vesna, et al.
Publicado: (2013)

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
por: Zhou, Jianxia, et al.
Publicado: (2019)

Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
por: Tosic, Vesna, et al.
Publicado: (2014)

De novo design of potent and selective mimics of IL-2 and IL-15
por: Silva, Daniel-Adriano, et al.
Publicado: (2019)

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
por: Roy, Sumedha, et al.
Publicado: (2023)

Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling
por: Guo, Na, et al.
Publicado: (2016)

An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers
por: Wang, Ninghai, et al.
Publicado: (2021)

Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
por: Huang, Cheng, et al.
Publicado: (2022)

Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo
por: Zuo, Ling, et al.
Publicado: (2020)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
por: Cha, Seung E., et al.
Publicado: (2021)

Multifunctional Benzothiadiazole-Based Small Molecules Displaying Solvatochromism and Sensing Properties toward Nitroarenes, Anions, and Cations**
por: Alfonso, María, et al.
Publicado: (2014)

(89)Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding
por: van Brummelen, Emilie M.J., et al.
Publicado: (2018)

BiHC, a T-Cell–Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells()
por: Xing, Jieyu, et al.
Publicado: (2017)

The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health
por: Roblin, Clarisse, et al.
Publicado: (2021)

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
por: Klein, Christian, et al.
Publicado: (2017)

Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
por: Fan, Yuying, et al.
Publicado: (2021)

Amphipathic Small Molecule AZT Compound Displays Potent Inhibitory Effects in Cancer Cell Proliferation
por: Gunasekaran, Pethaiah, et al.
Publicado: (2021)

Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
por: Zhao, Wenjing, et al.
Publicado: (2021)

CEA solenoide
por: Sylvie Prodon
Publicado: (2003)

Drug repurposing: Discovery of troxipide analogs as potent antitumor agents
por: Lu, Nan, et al.
Publicado: (2020)

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002)

S41. Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
por: Klein, C
Publicado: (2014)

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
por: Hsu, Eric J., et al.
Publicado: (2021)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway
por: Fang, Cheng, et al.
Publicado: (2021)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity
por: Van den Bergh, Johan, et al.
Publicado: (2015)

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
por: Yang, Min, et al.
Publicado: (2021)

Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways
por: Peng, Xuerun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3mo9cimpve0i3ob6g005nlf8j2